首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1681610

基因檢測市場規模、佔有率及成長分析（依技術、應用、產品、通路、最終用途及地區）－2025-2032 年產業預測

Genetic Testing Market Size, Share, and Growth Analysis, By Technology (Next Generation Sequencing, Array Technology), By Application (Ancestry & Ethnicity, Traits Screening), By Product, By Channel, By End Use, By Region - Industry Forecast 2025-2032

出版日期: 2025年03月08日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球基因檢測市場規模價值 80 億美元，預計將從 2024 年的 98.4 億美元成長到 2032 年的 515.5 億美元，預測期內（2025-2032 年）的複合年成長率為 23.0%。

由於技術進步、醫療保健需求增加以及公眾意識增強，基因檢測市場正在經歷顯著成長。這種快速成長主要歸功於針對各種健康狀況的提高意識和教育活動，以及廣泛的媒體報導。技術創新，尤其是次世代定序（NGS），大大提高了基因檢測的速度、準確性和可負擔性。然而，它面臨著道德和隱私挑戰，包括基因資訊的濫用以及保險和就業領域的潛在歧視。儘管存在這些障礙，但基因檢測的不斷應用和基因組學的持續進步為市場提供了巨大的成長機會，預示著個人化醫療和醫療保健解決方案的光明未來。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Illumina, Inc.（USA）
Roche Holding AG（Switzerland）
Thermo Fisher Scientific Inc.（USA）
QIAGEN NV（Netherlands）
Abbott Laboratories（USA）
Agilent Technologies, Inc.（USA）
Bio-Rad Laboratories, Inc.（USA）
Danaher Corporation（USA）
Myriad Genetics, Inc.（USA）
23andMe, Inc.（USA）
Invitae Corporation（USA）
Natera, Inc.（USA）
NeoGenomics, Inc.（USA）
Guardant Health, Inc.（USA）
Siemens Healthineers AG（Germany）
Hologic, Inc.（USA）
BGI Genomics Co., Ltd.（China）
Eurofins Scientific（Luxembourg）
Adaptive Biotechnologies Corporation（USA）

結論和建議

簡介目錄

Product Code: SQMIG35H2074

Global Genetic Testing Market size was valued at USD 8.0 billion in 2023 and is poised to grow from USD 9.84 billion in 2024 to USD 51.55 billion by 2032, growing at a CAGR of 23.0% during the forecast period (2025-2032).

The genetic testing market has experienced significant growth due to advancements in technology, increasing healthcare demands, and heightened public awareness. This surge is primarily driven by enhanced awareness and educational initiatives about various prevalent health conditions, supported by extensive media coverage. Technological innovations, particularly in Next-Generation Sequencing (NGS), have drastically improved the speed, accuracy, and affordability of genetic tests. However, the market faces challenges regarding ethical concerns and privacy issues, including the potential misuse of genetic information and discrimination from insurance or employment sectors. Despite these hurdles, the expanding applications of genetic testing and ongoing advancements in genomics present substantial growth opportunities for the market, signaling a promising future in personalized medicine and healthcare solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genetic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Genetic Testing Market Segments Analysis

Global Genetic Testing Market is segmented by Technology, Application, Product, Channel, End Use and region. Based on Technology, the market is segmented into Next Generation Sequencing, Array Technology, PCR - based Testing, FISH and Others. Based on Application, the market is segmented into Ancestry & Ethnicity, Traits Screening, Genetic Disease Carrier Status, New Baby Screening and Health and Wellness - Predisposition/ Risk / Tendency. Based on Product, the market is segmented into Consumables, Equipment and Software & Services. Based on Channel, the market is segmented into Online and Offline. Based on End Use, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Genetic Testing Market

The global genetic testing market is significantly propelled by the increasing awareness and demand for personalized medicine. As individuals become more informed about the benefits of tailored healthcare solutions, there is a substantial shift towards genetic testing, which provides valuable insights into a person's unique genetic makeup. This heightened awareness fosters a growing preference for personalized treatment plans that can enhance efficacy and minimize adverse effects. Additionally, advancements in technology and the consequential reduction in testing costs have further fueled consumer interest. Consequently, the focus on personalized approaches in medicine continuously drives the expansion of the genetic testing sector worldwide.

Restraints in the Global Genetic Testing Market

One of the significant challenges facing the global genetic testing market is the issue of limited insurance coverage. Many insurance providers are hesitant to fully cover genetic testing expenses, often due to high costs and perceived uncertainties regarding the benefits of various tests. This lack of comprehensive coverage can deter individuals from seeking necessary genetic assessments, as out-of-pocket expenses may be prohibitive for many patients. Consequently, this restriction hampers market growth by limiting access to testing services, which in turn affects patient outcomes and the overall demand for advancements in genetic testing technologies and services.

Market Trends of the Global Genetic Testing Market

The Global Genetic Testing market is witnessing a significant trend of expanding beyond traditional DNA analysis to incorporate advanced methodologies, including RNA profiling and epigenetic testing. This evolution is pivotal as it enhances the detection of genetic variations and provides profound insights into how these alterations influence gene expression and overall health. By considering factors that do not alter the DNA sequence yet affect cellular functionality, genetic testing is becoming more comprehensive and personalized. This trend is expected to drive demand for innovative testing solutions, ultimately leading to more precise healthcare interventions and tailored treatments, thereby propelling market growth in the coming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Genetic Testing Market Size by Technology & CAGR (2025-2032)

Market Overview
Next Generation Sequencing
Array Technology
PCR - based Testing
FISH
Others

Global Genetic Testing Market Size by Application & CAGR (2025-2032)

Market Overview
Ancestry & Ethnicity
Traits Screening
Genetic Disease Carrier Status
New Baby Screening
Health and Wellness - Predisposition/ Risk / Tendency

Global Genetic Testing Market Size by Product & CAGR (2025-2032)

Market Overview
Consumables
Equipment
Software & Services

Global Genetic Testing Market Size by Channel & CAGR (2025-2032)

Market Overview
Online
Offline

Global Genetic Testing Market Size by End Use & CAGR (2025-2032)

Market Overview
Hospitals & Clinics
Diagnostic Laboratories
Others

Global Genetic Testing Market Size & CAGR (2025-2032)

North America (Technology, Application, Product, Channel, End Use)
- US
- Canada
Europe (Technology, Application, Product, Channel, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Application, Product, Channel, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Application, Product, Channel, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Application, Product, Channel, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
23andMe, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invitae Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natera, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeoGenomics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guardant Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Genomics Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adaptive Biotechnologies Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments